Davanço, M.G.; Fortuny, M.; Scasso, A.; Meulman, J.; Costa, F.; da Silva, T.M.; Vianna, D.R.B.; Teixeira, L.d.S.; Bellorio, K.B.; Sampaio, A.C.C.;
et al. Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations. Pharmaceutics 2024, 16, 1249.
https://doi.org/10.3390/pharmaceutics16101249
AMA Style
Davanço MG, Fortuny M, Scasso A, Meulman J, Costa F, da Silva TM, Vianna DRB, Teixeira LdS, Bellorio KB, Sampaio ACC,
et al. Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations. Pharmaceutics. 2024; 16(10):1249.
https://doi.org/10.3390/pharmaceutics16101249
Chicago/Turabian Style
Davanço, Marcelo Gomes, Miguel Fortuny, Alejandro Scasso, Jessica Meulman, Fernando Costa, Thalita Martins da Silva, Débora Renz Barreto Vianna, Leonardo de Souza Teixeira, Karini Bruno Bellorio, Ana Carolina Costa Sampaio,
and et al. 2024. "Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations" Pharmaceutics 16, no. 10: 1249.
https://doi.org/10.3390/pharmaceutics16101249
APA Style
Davanço, M. G., Fortuny, M., Scasso, A., Meulman, J., Costa, F., da Silva, T. M., Vianna, D. R. B., Teixeira, L. d. S., Bellorio, K. B., Sampaio, A. C. C., & Vespasiano, C. F. P.
(2024). Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations. Pharmaceutics, 16(10), 1249.
https://doi.org/10.3390/pharmaceutics16101249
